- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03889223
Ultrasonographic and Comfort Comparison of Sitting Fetal Cross-legged Position With Lateral Decubitus Fetal Position
June 27, 2019 updated by: Fatma Ferda Kartufan, Yeditepe University
Ultrasonographic and Comfort Comparison of Sitting Fetal Cross-legged Position With Lateral Decubitus Fetal Position on Healthy Volunteers; a Randomized, Consecutive-controlled Clinical Trial
A prosperous neuraxial anesthesia positioning ensures a raised chance of successful needle placement. The primary aim is to compare "Sitting Cross-legged Fetal Position -SCF" with "Lateral Decubitus Fetal Position-LDF" anatomically via sonography.
Secondary aim is to compare their comfort.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Fifty participants were included to this prospective, randomized, consecutive controlled clinical study.
Six parameters were evaluated in each position; subcutaneous tissue (ST), skin to spinous process (S-SP), transverse diameters of bilateral paraspinal muscles (left paraspinal muscle [LPM] and right paraspinal muscle [RPM]), interspinous gap opening (ISGO), mean of bilateral paraspinal muscles (MPM).
The change of every measurement recorded via ultrasonography (USG) according to the positioning techniques were also calculated.
The calculations are explained briefly in primary outcomes (including the change of SCF-LDF in ST, S-SP, LPM, RPM, MPM, ISGO).
Stretcher comfort (SC), position comfort (PC), lumbar comfort (LC), and abdominal comfort (AC) were evaluated by the participants with the 7-point Numerical Rating Scale (NRS).
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
İçerenköy
-
Istanbul, İçerenköy, Turkey
- Yeditepe University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy and adult volunteers,
- must be able to do the sitting cross-legged fetal position ( SCF ),
- must be able to do the Lateral decubitus fetal position (LDF).
Exclusion Criteria:
- Lumbar hernia,
- Scoliosis,
- History of spine surgery,
- History of trauma,
- History of lower back pain,
- Arthropathy {especially pelvic or knee problems},
- Could not be able to do one or both of the two neuraxial position techniques.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: SEQUENTIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: The LDF neuraxial positioning technique
In the LDF neuraxial positioning technique, fifty participants were planned to lay down the stretcher facing the wall of the sonography room and turned back to the consultant Radiologist.
Volunteers jaw touch to chest and legs in abdominal flexion with hands are on the knees.
The position is completed with the back curved in the fetal position.
Then the USG is performed by the consultant Radiology M.D. in maximum 2 hours time to each participant, and the 7-point NRS evaluation is done by each participant in maximum 30 minutes time until the study ends within 15 weeks.
|
The anatomical evaluation of the two neuraxial positioning techniques sonographically and comparison of comfort with the 7-point NRS
|
|
EXPERIMENTAL: The SCF neuraxial positioning technique
In the SCF neuraxial positioning technique, the same fifty participants were planned to sit on the same part of the stretcher facing the wall of the sonography room and turned back to the consultant Radiologist with legs crossed, forearms of the participants are on the lap and hands are on the knees, and the position is completed with the back curved in the fetal position.Then the USG is performed by the consultant Radiology M.D. in maximum 2 hours time to each participant, and the 7-point NRS evaluation is done by each participant in maximum 30 minutes time until the study ends within 15 weeks.
|
The anatomical evaluation of the two neuraxial positioning techniques sonographically and comparison of comfort with the 7-point NRS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interspinous gap opening (ISGO) measurement in the SCF
Time Frame: For the SCF technique, ISGO is measured in the first 10 minutes(mins.) time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the wideness measurement of the ISGO in millimeters via ultrasonography (USG) in the SCF
|
For the SCF technique, ISGO is measured in the first 10 minutes(mins.) time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Left paraspinal muscle (LPM) measurements in the SCF
Time Frame: For the SCF technique, LPM is measured between the 10th and 20th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the diameter measurement of the LPM in millimeters via ultrasonography in the SCF
|
For the SCF technique, LPM is measured between the 10th and 20th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Right paraspinal muscle (RPM) measurements in the SCF
Time Frame: For the SCF technique, RPM is measured in between the 20th and 30th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the diameter measurement of the RPM in millimeters via ultrasonography in the SCF
|
For the SCF technique, RPM is measured in between the 20th and 30th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
The mean of bilateral paraspinal muscles (MPM) in the SCF
Time Frame: For the SCF technique, MPM measurement is planned to be done in between the 30th and 40th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by ( [LPM+RPM]/2) in millimeters in the SCF
|
For the SCF technique, MPM measurement is planned to be done in between the 30th and 40th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Subcutaneous tissue (ST) measurements in the SCF
Time Frame: For the SCF technique, ST measurement is planned to be done in between the 40th and 50th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the SCF
|
For the SCF technique, ST measurement is planned to be done in between the 40th and 50th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
The skin to spinous process (S-SP) measurements in the SCF
Time Frame: : For the SCF technique, S-SP measurement is planned to be done in between the 50th and 60th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the SCF
|
: For the SCF technique, S-SP measurement is planned to be done in between the 50th and 60th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Interspinous gap opening (ISGO) measurement in the LDF
Time Frame: ISGO measurement in the LDF will be done right after NRS evaluation of the SCF, in between the 70th and 80th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the wideness measurement of the ISGO in millimeters via ultrasonography in the LDF
|
ISGO measurement in the LDF will be done right after NRS evaluation of the SCF, in between the 70th and 80th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Left paraspinal muscle (LPM) measurements in the LDF
Time Frame: LPM measurement in the LDF will be done in between the 80th and 90th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the diameter measurement of the LPM in millimeters via ultrasonography in the LDF
|
LPM measurement in the LDF will be done in between the 80th and 90th mins. of the study,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Right paraspinal muscle (RPM) measurements in the LDF
Time Frame: RPM measurement in the LDF will done in between the 90th and 100th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant through study completion up to 20 weeks.
|
the diameter measurement of the RPM in millimeters via ultrasonography in the LDF
|
RPM measurement in the LDF will done in between the 90th and 100th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant through study completion up to 20 weeks.
|
|
The mean of bilateral paraspinal muscles (MPM) in the LDF
Time Frame: MPM measurement in the LDF will be done in between the 100th and 110th mins. time of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by ( [LPM+RPM]/2) in millimeters in the LDF
|
MPM measurement in the LDF will be done in between the 100th and 110th mins. time of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
Subcutaneous tissue (ST) measurements in the LDF
Time Frame: ST measurement in the LDF will be done in between the 110th and 120th mins. time, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the thickness measurement of the subcutaneous tissue in millimeters via ultrasonography in the LDF
|
ST measurement in the LDF will be done in between the 110th and 120th mins. time, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
The skin to spinous process (S-SP) measurements in the LDF
Time Frame: S-SP measurement in the LDF will be done in between the 120th and 130th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
the depth measurement of the skin to spinous process in millimeters via ultrasonography in the LDF
|
S-SP measurement in the LDF will be done in between the 120th and 130th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of ISGO (ISGO SCF-LDF)
Time Frame: ISGO in the SCF measured in the first 10mins., and ISGO in the LDF measured in between the 70th and 80th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation; ([ISGO in the SCF in millimeters]-[ISGO in the LDF in millimeters])
|
ISGO in the SCF measured in the first 10mins., and ISGO in the LDF measured in between the 70th and 80th mins. of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of LPM (LPM SCF-LDF )
Time Frame: LPM in the SCF measured in between the 10th and 20th mins., and LPM in the LDF measured in between the 80th and 90th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation; ([LPM in SCF in millimeters]-[LPM in LDF in millimeters])
|
LPM in the SCF measured in between the 10th and 20th mins., and LPM in the LDF measured in between the 80th and 90th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of RPM (RPM SCF-LDF)
Time Frame: RPM in the SCF measured in between the 20th and 30th mins., and RPM in the LDF measured in between 90th and 100th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation ([RPM in SCF in millimeters]-[RPM in LDF in millimeters])
|
RPM in the SCF measured in between the 20th and 30th mins., and RPM in the LDF measured in between 90th and 100th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of MPM (MPM SCF-LDF)
Time Frame: MPM in the SCF measured in between the 30th and 40th mins., and MPM in the LDF measured in between 100th and 110th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation ([MPM in SCFin millimeters]-[MPM in LDF in millimeters])
|
MPM in the SCF measured in between the 30th and 40th mins., and MPM in the LDF measured in between 100th and 110th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of ST (ST SCF-LDF)
Time Frame: ST in the SCF measured in between the 40th and 50th mins., and ST in the LDF measured in between the 110th and 120th, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation ([ST in SCF in millimeters]-[ST in LDF in millimeters])
|
ST in the SCF measured in between the 40th and 50th mins., and ST in the LDF measured in between the 110th and 120th, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
|
the change of S-SP (S-SP SCF-LDF)
Time Frame: S-SP in the SCF measured in between the 50th and 60th mins., and S-SP in the LDF measured in between the 120th and 130th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Measured by calculation ([S-SP in SCF in millimeters]-[S-SP in LDF in millimeters])
|
S-SP in the SCF measured in between the 50th and 60th mins., and S-SP in the LDF measured in between the 120th and 130th mins., in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort evaluation in the SCF via 7-point numerical rating scale (NRS)
Time Frame: NRS measurement is planned to be done right after the SCF position in between the 60th and 70th mins. time,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks..
|
Comfort evaluation of the SCF technique is planned to be done by the participant right after USG.
The 7-point NRS includes 7 scale.
The minimum scale is"1" means very bad, "2" means bad, "3" means fair, "4" means normal, "5" means good, "6" means very good, and the maximum scale is "7" means excellent.
|
NRS measurement is planned to be done right after the SCF position in between the 60th and 70th mins. time,in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks..
|
|
Comfort evaluation in the LDF via 7-point numerical rating scale (NRS)
Time Frame: NRS measurement is planned to be done right after the LDF position in between the 130th and 140th mins. time of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Comfort evaluation of the LDF technique is planned to be done by the participant right after USG.
The 7-point NRS includes 7 scale.
The minimum scale is"1" means very bad, "2" means bad, "3" means fair, "4" means normal, "5" means good, "6" means very good, and the maximum scale is "7" means excellent.
|
NRS measurement is planned to be done right after the LDF position in between the 130th and 140th mins. time of the study, in 10 mins. time of the total 3hr and 30 mins. study, for each participant, through study completion up to 20 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ferda Kartufan, Assist.Prof., Anesthesiology and Reanimation Department
- Study Chair: Feyza Aksu, MD, Anesthesiology and Reanimation Department
- Study Director: Özge Köner, Prof., Anesthesiology and Reanimation Department
- Study Chair: Ayşegül Görmez, Consult.MD, Radiology Department
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 20, 2019
Primary Completion (ACTUAL)
June 15, 2019
Study Completion (ACTUAL)
June 25, 2019
Study Registration Dates
First Submitted
March 12, 2019
First Submitted That Met QC Criteria
March 25, 2019
First Posted (ACTUAL)
March 26, 2019
Study Record Updates
Last Update Posted (ACTUAL)
July 1, 2019
Last Update Submitted That Met QC Criteria
June 27, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KAEK- tez
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia, Conduction
-
University of New MexicoCompletedAnesthesia, ConductionUnited States
-
University Health Network, TorontoCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedAnesthesia, ConductionUnited States
-
Hospital Authority, Hong KongCompletedSurgery | Anesthesia, ConductionChina
-
University of TorontoMount Sinai Hospital, CanadaCompletedArthroplasty, Replacement, Knee | Anesthesia, ConductionCanada
-
Yeditepe UniversityCompletedAnesthesia, ConductionTurkey
-
Bozyaka Training and Research HospitalCompletedComparison of Sympathetic Blockade Duration in Brachial Plexus Blocks Performed by Different MethodsBrachial Plexus Blockade | Anesthesia, Conduction | Sympathetic BlockadeTurkey (Türkiye)
-
Centre Hospitalier Universitaire de BesanconCompletedDexamethasone | Ropivacaine | Anesthesia, Conduction | Axillary Brachial Plexus BlockFrance
-
AZ Sint-Jan AVCompletedAnesthesia, ConductionBelgium
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Health Sciences Centre; St. Joseph...CompletedNerve Block | Regional Blood Flow | Anesthesia, Conduction | Sympathectomy
Clinical Trials on Anatomical intervention with USG and comfort evaluation with NRS
-
Sezen Kumaş SolakBagcilar Training and Research HospitalNot yet recruitingINTRACRANIAL TUMOR | INTRACRANIAL PRESSURE | OPTIC NERVE
-
nurmuhammet tasNot yet recruitingLateral Epicondylitis
-
National Health Service, United KingdomSouthern Health and Social Care TrustCompleted
-
Baskent UniversityCompletedBreast NeoplasmsTurkey
-
Mansoura UniversityNot yet recruitingPost-mastectomy Pain Syndrome
-
Ankara UniversityBengi Safak; Ahmet Onat Bermede; Ayşegül GüvenCompletedCatheterization | CannulationTurkey
-
Malatya Egitim Ve Arastirma HastanesiCompletedPerfusion Index and Pleth Variability Index an Early Indicator of the Success of Brachial Plexus Block; Randomized Clinical TrialTurkey
-
Shuguo Zheng, MDUnknownLiver Diseases | Liver Neoplasms | Hepatic HaemangiomaChina
-
Hospital de MataróCentro Investigación Biomédica en Red de Enfermedades Hepáticas DigestivasCompletedCOVID-19 | Oropharyngeal Dysphagia | Nutrition | Sars-CoV2Spain
-
The Hospital for Sick ChildrenXiamen Children's HospitalNot yet recruitingNecrotizing Enterocolitis | PrematureChina